Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 16-Feb-24 6:37 PM View:  | van Der Horst Edward Chief Scientific Officer | Sensei Biotherapeutics, Inc. (SNSE) | 15-Feb-24 | Payment of Exercise | 2,843 | $0.79 | $2,245.97 | (5%) 58.91K to 56.07K | |
| 16-Feb-24 6:28 PM View: | Celebi John President and CEO Director | Sensei Biotherapeutics, Inc. (SNSE) | 15-Feb-24 | Payment of Exercise | 5,891 | $0.79 | $4,653.89 | (5%) 111.31K to 105.42K | |
| 16-Feb-24 6:25 PM View: | Colgan Erin Chief Financial Officer | Sensei Biotherapeutics, Inc. (SNSE) | 15-Feb-24 | Payment of Exercise | 3,627 | $0.79 | $2,865.33 | (5%) 71.09K to 67.46K | |
| 13-Sep-23 8:43 AM View: | Celebi John President and CEO Director | Sensei Biotherapeutics, Inc. (SNSE) | 11-Sep-23 | Private Purchase | 500 | $0.85 | $425.00 | < 1% 110.81K to 111.31K | |
| 02-Aug-23 5:06 PM View: | Peyer James Director 10% Owner | Sensei Biotherapeutics, Inc. (SNSE) | 31-Jul-23 | Disposition Duplicate | 1,587,300 | $1.26 | $2,000,000.00 | (30%) 5.24M to 3.65M | |
| 02-Aug-23 5:09 PM View: | Cambrian Biopharma Inc 10% Owner | Sensei Biotherapeutics, Inc. (SNSE) | 31-Jul-23 | Disposition | 1,587,300 | $1.26 | $2,000,000.00 | (30%) 5.24M to 3.65M | |
| 12-Jul-23 4:29 PM View: | Peyer James Director 10% Owner | Sensei Biotherapeutics, Inc. (SNSE) | 10-Jul-23 | Grant Duplicate | 4,466 | -- | -- | < 1% 5.24M to 5.24M | |
| 12-Jul-23 4:46 PM View: | Vojta Deneen Director | Sensei Biotherapeutics, Inc. (SNSE) | 10-Jul-23 | Grant | 4,466 | -- | -- | 100% 4.47K to 8.93K | |
| 12-Jul-23 5:00 PM View: | Broder Samuel Director | Sensei Biotherapeutics, Inc. (SNSE) | 10-Jul-23 | Grant | 4,466 | -- | -- | 100% 4.47K to 8.93K | |
| 12-Jul-23 5:02 PM View: | Ricks Thomas G Director | Sensei Biotherapeutics, Inc. (SNSE) | 10-Jul-23 | Grant | 4,466 | -- | -- | 1% 339.4K to 343.86K | |
| 12-Jul-23 4:50 PM View: | Humer Kristian Director | Sensei Biotherapeutics, Inc. (SNSE) | 10-Jul-23 | Grant | 4,466 | -- | -- | 100% 4.47K to 8.93K | |
| 12-Jul-23 5:03 PM View: | Ringo William R Director | Sensei Biotherapeutics, Inc. (SNSE) | 10-Jul-23 | Grant | 4,466 | -- | -- | 24% 18.93K to 23.4K | |
| 12-Jul-23 4:27 PM View: | Cambrian Biopharma Inc 10% Owner | Sensei Biotherapeutics, Inc. (SNSE) | 10-Jul-23 | Grant | 4,466 | -- | -- | < 1% 5.24M to 5.24M | |
| 12-Jul-23 4:44 PM View: | Holmen Bob Director | Sensei Biotherapeutics, Inc. (SNSE) | 10-Jul-23 | Grant | 4,466 | -- | -- | 21% 21.13K to 25.6K | |
| 12-Jul-23 4:48 PM View: | English Jessie Director | Sensei Biotherapeutics, Inc. (SNSE) | 10-Jul-23 | Grant | 4,466 | -- | -- | 100% 4.47K to 8.93K | |
| 02-Jun-23 5:03 PM View: | Apeiron Investment Group Ltd. 10% Owner | Sensei Biotherapeutics, Inc. (SNSE) | 01-Jun-23 | Sale | 3,441,660 | $1.58 | $5,437,820.00 | (100%) 3.44M to 0 | |
| 27-Feb-23 8:10 PM View: | Apeiron Investment Group Ltd. 10% Owner | Sensei Biotherapeutics, Inc. (SNSE) | 23-Feb-23 | Private Purchase | 2,200 | $1.61 | $3,539.03 | < 1% 3.44M to 3.44M | |
| 17-Feb-23 5:01 PM View: | Gallagher Patrick Stephen Chief Business Officer | Sensei Biotherapeutics, Inc. (SNSE) | 15-Feb-23 | Grant | 43,513 | -- | -- | 2175650% 2 to 43.52K | |
| 17-Feb-23 10:00 PM View: | Celebi John President and CEO Director | Sensei Biotherapeutics, Inc. (SNSE) | 15-Feb-23 | Grant | 73,193 | -- | -- | 135% 54.11K to 127.31K | |
| 11-Sep-23 5:31 PM View: | Colgan Erin Chief Financial Officer | Sensei Biotherapeutics, Inc. (SNSE) | 15-Feb-23 | Payment of Exercise | 10,943 | $1.50 | $16,414.50 | (14%) 79.03K to 68.09K | |
| 11-Sep-23 5:34 PM View: | Gallagher Patrick Stephen Chief Business Officer | Sensei Biotherapeutics, Inc. (SNSE) | 15-Feb-23 | Payment of Exercise | 9,383 | $1.50 | $14,074.50 | (22%) 43.51K to 34.13K | |
| 17-Feb-23 5:01 PM View: | van Der Horst Edward Chief Scientific Officer | Sensei Biotherapeutics, Inc. (SNSE) | 15-Feb-23 | Grant | 41,265 | -- | -- | 195% 21.17K to 62.44K | |
| 11-Sep-23 5:33 PM View: | Celebi John President and CEO Director | Sensei Biotherapeutics, Inc. (SNSE) | 15-Feb-23 | Payment of Exercise | 20,492 | $1.50 | $30,738.00 | (16%) 131.3K to 110.81K | |
| 11-Sep-23 5:33 PM View: | van Der Horst Edward Chief Scientific Officer | Sensei Biotherapeutics, Inc. (SNSE) | 15-Feb-23 | Payment of Exercise | 9,525 | $1.50 | $14,287.50 | (15%) 62.44K to 52.91K | |
| 17-Feb-23 5:01 PM View: | Colgan Erin Chief Financial Officer | Sensei Biotherapeutics, Inc. (SNSE) | 15-Feb-23 | Grant | 51,346 | -- | -- | 237% 21.69K to 73.03K | |
| 14-Jun-22 4:15 PM View: | Broder Samuel Director | Sensei Biotherapeutics, Inc. (SNSE) | 10-Jun-22 | Grant | 4,466 | -- | -- | 100% 0 to 4.47K | |
| 14-Jun-22 4:15 PM View: | Ricks Thomas G Director | Sensei Biotherapeutics, Inc. (SNSE) | 10-Jun-22 | Grant | 4,466 | -- | -- | 1% 334.93K to 339.4K | |
| 14-Jun-22 4:15 PM View: | Humer Kristian Director | Sensei Biotherapeutics, Inc. (SNSE) | 10-Jun-22 | Grant | 4,466 | -- | -- | 100% 0 to 4.47K | |
| 14-Jun-22 4:55 PM View: | Cambrian Biopharma Inc 10% Owner | Sensei Biotherapeutics, Inc. (SNSE) | 10-Jun-22 | Grant | 4,466 | -- | -- | < 1% 5.23M to 5.24M | |
| 14-Jun-22 4:15 PM View: | Holmen Bob Director | Sensei Biotherapeutics, Inc. (SNSE) | 10-Jun-22 | Grant | 4,466 | -- | -- | 27% 16.67K to 21.13K | |
| 14-Jun-22 4:15 PM View: | English Jessie Director | Sensei Biotherapeutics, Inc. (SNSE) | 10-Jun-22 | Grant | 4,466 | -- | -- | 100% 0 to 4.47K | |
| 14-Jun-22 4:54 PM View: | Peyer James Director 10% Owner | Sensei Biotherapeutics, Inc. (SNSE) | 10-Jun-22 | Grant Duplicate | 4,466 | -- | -- | < 1% 5.23M to 5.24M | |
| 14-Jun-22 4:15 PM View: | Vojta Deneen Director | Sensei Biotherapeutics, Inc. (SNSE) | 10-Jun-22 | Grant | 4,466 | -- | -- | 100% 0 to 4.47K | |
| 09-Mar-22 6:24 PM View: | Ringo William R Director | Sensei Biotherapeutics, Inc. (SNSE) | 08-Mar-22 | Grant | 18,933 | -- | -- | 100% 0 to 18.93K | |
| 02-Mar-22 1:42 PM View: | Cambrian Biopharma Inc 10% Owner | Sensei Biotherapeutics, Inc. (SNSE) | 02-Mar-22 | Private Purchase | 1,203 | $3.20 | $3,849.60 | < 1% 5.23M to 5.23M | |
| 02-Mar-22 1:40 PM View: | Peyer James Director 10% Owner | Sensei Biotherapeutics, Inc. (SNSE) | 02-Mar-22 | Private Purchase Duplicate | 1,203 | $3.20 | $3,849.60 | < 1% 5.23M to 5.23M | |
| 01-Mar-22 6:55 PM View: | Peyer James Director 10% Owner | Sensei Biotherapeutics, Inc. (SNSE) | 01-Mar-22 | Purchase Duplicate | 2,458 | $3.60 | $8,848.80 | < 1% 5.23M to 5.23M | |
| 01-Mar-22 6:53 PM View: | Cambrian Biopharma Inc 10% Owner | Sensei Biotherapeutics, Inc. (SNSE) | 01-Mar-22 | Purchase | 2,458 | $3.60 | $8,848.80 | < 1% 5.23M to 5.23M | |
| 01-Mar-22 6:53 PM View: | Cambrian Biopharma Inc 10% Owner | Sensei Biotherapeutics, Inc. (SNSE) | 28-Feb-22 | Private Purchase | 42 | $3.60 | $151.20 | < 1% 5.23M to 5.23M | |
| 01-Mar-22 6:55 PM View: | Peyer James Director 10% Owner | Sensei Biotherapeutics, Inc. (SNSE) | 28-Feb-22 | Private Purchase Duplicate | 42 | $3.60 | $151.20 | < 1% 5.23M to 5.23M | |
| 28-Feb-22 4:53 PM View: | Peyer James Director 10% Owner | Sensei Biotherapeutics, Inc. (SNSE) | 25-Feb-22 | Private Purchase Duplicate | 2,500 | $3.65 | $9,125.00 | < 1% 5.23M to 5.23M | |
| 28-Feb-22 10:00 PM View: | Cambrian Biopharma Inc 10% Owner | Sensei Biotherapeutics, Inc. (SNSE) | 25-Feb-22 | Private Purchase | 2,500 | $3.65 | $9,125.00 | < 1% 5.23M to 5.23M | |
| 24-Feb-22 7:12 PM View: | Peyer James Director 10% Owner | Sensei Biotherapeutics, Inc. (SNSE) | 24-Feb-22 | Purchase Duplicate | 15,000 | $3.63 | $54,450.00 | < 1% 5.21M to 5.23M | |
| 24-Feb-22 7:15 PM View: | Cambrian Biopharma Inc 10% Owner | Sensei Biotherapeutics, Inc. (SNSE) | 24-Feb-22 | Purchase | 15,000 | $3.63 | $54,450.00 | < 1% 5.21M to 5.23M | |
| 24-Feb-22 7:15 PM View: | Cambrian Biopharma Inc 10% Owner | Sensei Biotherapeutics, Inc. (SNSE) | 23-Feb-22 | Private Purchase | 2,500 | $3.80 | $9,500.00 | < 1% 5.21M to 5.21M | |
| 24-Feb-22 7:12 PM View: | Peyer James Director 10% Owner | Sensei Biotherapeutics, Inc. (SNSE) | 23-Feb-22 | Private Purchase Duplicate | 2,500 | $3.80 | $9,500.00 | < 1% 5.21M to 5.21M | |
| 22-Feb-22 11:36 AM View: | Peyer James Director 10% Owner | Sensei Biotherapeutics, Inc. (SNSE) | 18-Feb-22 | Purchase Duplicate | 15,000 | $3.97 | $59,550.00 | < 1% 5.19M to 5.21M | |
| 22-Feb-22 11:35 AM View: | Cambrian Biopharma Inc 10% Owner | Sensei Biotherapeutics, Inc. (SNSE) | 18-Feb-22 | Purchase | 15,000 | $3.97 | $59,550.00 | < 1% 5.19M to 5.21M | |
| 22-Feb-22 11:35 AM View: | Cambrian Biopharma Inc 10% Owner | Sensei Biotherapeutics, Inc. (SNSE) | 17-Feb-22 | Private Purchase | 4,949 | $4.17 | $20,637.30 | < 1% 5.19M to 5.19M | |
| 22-Feb-22 11:36 AM View: | Peyer James Director 10% Owner | Sensei Biotherapeutics, Inc. (SNSE) | 17-Feb-22 | Private Purchase Duplicate | 4,949 | $4.17 | $20,637.30 | < 1% 5.19M to 5.19M |
